RWJ Health Connect | Patient PortalGo
  • 1-888-MD-RWJUH
  • YouTube

Health Library

Results 1 - 10 of 1570
Search Results:  n (1570)
  • No Fruit Juice Before Age 1, Pediatricians Say

    Posted: 05/25/2017

    No Fruit Juice Before Age 1, Pediatricians Say MONDAY, May 22, 2017 (HealthDay News) -- Several new recommendations from the American Academy of Pediatrics may just send toddlers into tantrums. One recommendation is that fruit juice be limited for toddlers and older children, and babies shouldn't have any at all before their first birthday. Another recommendation is that parents should forgo the beloved sippy cup of juice for their children altogether. The advice is the first update to the AAP's stance ...

  • New FDA Head Outlines 'Forceful Steps' Against Opioid Crisis

    Posted: 05/25/2017

    New FDA Head Outlines 'Forceful Steps' Against Opioid Crisis TUESDAY, May 23, 2017 (HealthDay News) -- The new U.S. Food and Drug Administration commissioner has called on senior agency officers to develop "more forceful steps" to control the U.S. opioid epidemic. On Tuesday, Dr. Scott Gottlieb, President Trump's pick for the agency, announced the formation of an opioid policy steering committee to explore and develop additional approaches to confront the crisis. One solution, he said, is to cut back on...

  • New Drug Approved for All Cancers With Genetic Marker

    Posted: 05/25/2017

    New Drug Approved for All Cancers With Genetic Marker TUESDAY, May 23, 2017 (HealthDay News) -- Keytruda (pembrolizumab) has been approved by the U.S. Food and Drug Administration to treat any cancer that has a certain genetic biomarker, regardless of where in the body the cancer originated. "This is an important first for the cancer community," said Dr. Richard Pazdur, acting director of the agency's Office of Hematology and Oncology Products. "Until now, the FDA has approved cancer treatments based on...

  • New Cholesterol Fighting Meds Target Key Gene

    Posted: 05/25/2017

    New Cholesterol Fighting Meds Target Key Gene THURSDAY, May 25, 2017 (HealthDay News) -- New gene-based therapies appear to significantly decrease cholesterol levels in people, and could even cut down on arterial plaque, according to results from two early drug trials. Both treatments improve the body's ability to break down cholesterol by targeting a specific gene that inhibits that function, researchers reported. The angiopoietin-like 3 (ANGPTL3) gene normally restrains proteins involved in the breakd...

  • Nuts! Good Medicine for Colon Cancer Survivors?

    Posted: 05/24/2017

    Nuts! Good Medicine for Colon Cancer Survivors? WEDNESDAY, May 17, 2017 (HealthDay News) -- Colon cancer patients might improve their chances of survival if they eat nuts along with an overall healthy diet and regular exercise, two new studies report. In a seven-year study, patients successfully treated for stage 3 colon cancer who ate at least 2 ounces of nuts a week had a 42 percent lower chance of their cancer coming back and a 57 percent lower risk of dying from the disease. Stage 3 means the cancer...

  • New Hepatitis C Infections Hit 15-Year High: CDC

    Posted: 05/21/2017

    New Hepatitis C Infections Hit 15-Year High: CDC FRIDAY, May 12, 2017 (HealthDay News) -- Reports of new hepatitis C infections in the United States nearly tripled over five years, reaching a 15-year high, federal government data show. The highest number of new infections were reported among 20- to 29-year-olds. Many stemmed from the growing use of injected drugs linked to the current opioid epidemic, officials said. The number of reported cases rose from 850 in 2010 to 2,436 in 2015, according to the U...

  • New Device Approved for Esophageal Birth Defect

    Posted: 05/21/2017

    New Device Approved for Esophageal Birth Defect MONDAY, May 15, 2017 (HealthDay News) -- A new medical device has been approved by the U.S. Food and Drug Administration to treat esophageal atresia, a birth defect that causes a gap between the esophagus and stomach. One of 2,500 babies in the United States is born with the condition, the agency said in a news release. These infants require a feeding tube until surgery is performed to connect the esophagus to the stomach. Many babies born with the conditi...

  • New Hepatitis C Treatments More Effective, Tolerable: FDA

    Posted: 05/18/2017

    New Hepatitis C Treatments More Effective, Tolerable: FDA THURSDAY, May 11, 2017 (HealthDay News) -- Hepatitis C can be cured in about three months, allowing people with the viral disease to live longer, healthier lives, the U.S. Food and Drug Administration (FDA) says. Drugs used to clear the virus from the body are not only more effective than they once were but also more tolerable for patients, according to Dr. Jeffrey Murray, an internist at the FDA who specializes in infectious diseases. Hepatitis ...

  • New Guidelines Say No to Most 'Keyhole' Knee Surgeries

    Posted: 05/17/2017

    New Guidelines Say No to Most 'Keyhole' Knee Surgeries WEDNESDAY, May 10, 2017 (HealthDay News) -- "Keyhole" arthroscopic surgery should rarely be used to repair arthritic knee joints, a panel of international experts says in new clinical guidelines. Clinical trials have shown that keyhole surgery doesn't help people suffering from arthritis of the knees any more than mild painkillers, physical therapy or weight loss, said lead author Dr. Reed Siemieniuk. He is a health researcher with McMaster Universi...

  • Nearly a Third of Drugs Hit by Safety Issues After FDA Approval

    Posted: 05/17/2017

    Nearly a Third of Drugs Hit by Safety Issues After FDA Approval WEDNESDAY, May 10, 2017 (HealthDay News) -- Safety problems emerge with nearly one in three prescription drugs after they've been approved by the U.S. Food and Drug Administration, a new study reveals. Researchers examined data on drugs approved by the FDA between 2001 and 2010, with follow-up through 2017. The investigators found that 32 percent of the drugs had safety issues after approval. "That is very rarely a drug withdrawal, but more...